low dose glp-1 Microdosed (Semaglutide) GLP-1 Microdosing Explained - Gift

9,8g C8 ( ) 4,2g C10 ( )

Barone A, Rubin JB

When activated, these receptors trigger several beneficial effects: Enhanced insulin secretion in response to elevated blood glucose levels Suppression of glucagon release , reducing hepatic glucose production Delayed gastric emptying , which promotes satiety and reduces appetite Direct effects on appetite centres in the hypothalamus, leading to reduced food intake Commonly prescribed GLP-1 receptor agonists available in the UK include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), and exenatide (Byetta, Bydureon)

Stopping abruptly often results in regaining about two-thirds of the lost weight within 10 to 12 months

Maintains eye health and vision: Formulated to provide comprehensive eye support